Aquilo Capital Management Overview

  • Investor Type
  • Hedge Fund
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 3
  • Portfolio
  • 2
  • Exits
  • 1
Exits

Aquilo Capital Management General Information

Description

Founded in 2010, Aquilo Capital Management is a global hedge fund manager based in San Francisco, California. The firm employs a long-only and volatility strategy and invests in companies operating in the drug development and biotechnology sectors across the United States and Non-United states. It also seeks to achieve substantial risk-adjusted returns.

Contact Information

Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Primary Office
  • One Letterman Drive
  • Suite D4900
  • San Francisco, CA 94129
  • United States
+1 (415) 000-0000

Aquilo Capital Management Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Amryt Pharma 08-Dec-2020 PIPE 0000 Drug Delivery Generating Revenue/Not Profitable
000000000 01-Apr-2014 0000 000.00 Biotechnology Generating Revenue/Not Profitable
000000000 00000000 11-Oct-2013 0000 0000 Biotechnology Generating Revenue/Not Profitable
To view Aquilo Capital Management’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aquilo Capital Management Exits (1)

Company Name Exit Date Exit Type Exit Size
000000000 00000000 24-Feb-2014 000000 0000000000 00000
To view Aquilo Capital Management’s complete exits history, request access »

Aquilo Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Aquilo Capital Management Team (8)

Name Title Deals Funds Boards Office
Marc Schneidman Chief Investment Officer & Portfolio Manager San Francisco, CA
Megan Pelsis Director, Investor Relations & Operations San Francisco, CA
Adam Bristol Ph.D Director of Investments San Francisco, CA
Patrick Rivers Director of Research San Francisco, CA
Roman Camarda Ph.D Analyst San Francisco, CA
You’re viewing 5 of 8 team members. Get the full list »